EDB, ADB to finance projects of $3 billion total cost in Armenia, Kyrgyzstan, Kazakhstan and Tajikistan

YEREVAN, May 11. /ARKA/. The Eurasian Development Bank and the Asian Development Bank will finance a number of projects of $3 billion total cost in Armenia, Kyrgyzstan, Kazakhstan and Tajikistan, the Eurasian Development Bank reports on its website.

According to the report, the banks will target their joint financing for transport and energy infrastructures as well as agriculture.

Eurasian Development Bank was established by Russia and Kazakhstan in January 2006 to foster development of market economies of participant countries.

The bank’s member countries are Armenia ($100,000), Belarus ($15 million), Kazakhstan ($500 million), Kyrgyzstan ($100,000), Russia ($1 billion) and Tajikistan ($500,000).

The Eurasian Fund for Stabilization and Development was instituted on June 9, 2009 with $8.513 billion by the governments of these six countries. –0—-

spot_img

POPULAR

US dollar, euro, and ruble drop against Armenian dram

YEREVAN, August 18. /ARKA/. The average market exchange rate for the US dollar against the Armenian dram on the Armenian foreign exchange market as of August 18, 2026, fell by 0.25 points to 365.25 drams compared to August 17.

Armbanks Weekly Digest: Key Events in Armenia’s Financial Market (August 10-16)

YEREVAN, August 17. /ARKA/. Armenia's financial agenda last week focused on setting up payment and cryptocurrency infrastructure, capital market activity, and the parameters of the next stage of universal health insurance.

US dollar, euro, and ruble up against  Armenian dram

YEREVAN, August 20. /ARKA/. The average market exchange rate for the US dollar to the Armenian dram on the Armenian foreign exchange market as of August 20, 2026, increased by 0.3 points to 365.26 drams compared to August 19.

US dollar and ruble drop against Armenian dram      

YEREVAN, August 17. /ARKA/. The average market exchange rate for the US dollar against the Armenian dram on the Armenian foreign exchange market, fell by 0.32 points on August 17, 2026, compared to August 14, to 365.82 drams.

Shares of Noubar Afeyan’s Moderna soared 124% on news of a successful cancer vaccine trial

YEREVAN, August 20. /ARKA/. Shares of the biotech company Moderna soared 123.6% at the start of trading in the US on August 19, reaching a peak of $140.77, according to trading data. Shares of the pharmaceutical company Merck also rose 11.6% to $150.85, according to Forbes.ru.

LATEST NEWS

spot_imgspot_imgspot_img